MarkWide Research

Sale!

Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry, Statistics, and Covid-19 Impact Analysis, By Type(ELISA HEV IgM Test kits, ELISA HEV IgG Test kits, RT-PCR Test kits, Other), By End User(Hospitals, Research Centers, Diagnostic Laboratories, Point of Care) and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 179
Delivery Format: PDF + Excel

$2,950.00

Hepatitis E Diagnostic Tests Market Size Analysis Overview:

Global Hepatitis E Diagnostic Tests Market was estimated at USD 52.4 Million in 2021. It is expected to grow at a CAGR of 4.5% between 2022 and 2030.

Hepatitis E is an infection caused by viruses that affect the liver. It is often transmitted through unclean water. The majority of cases are seen in developing countries with inadequate sanitation facilities. The most frequent symptoms of Hepatitis E include fatigue, fever, loss of appetite, nausea, abdominal pain, vomiting, jaundice, and dark urine.

Many tests are used for identifying Hepatitis E, including liver function tests, serological tests for nucleic acids, and imaging tests. Liver function tests are among the most commonly utilized tests to aid in the detection of hepatitis E since they are quick and easy to do and cost a lot of money. The hepatitis E diagnostic test market is classified according to technology, product, users, and geography.

Based on the product, Hepatitis E Diagnostic Market is classified as kits, reagents, instruments, and software and services. The category of reagents and kits is anticipated to expand at the fastest CAGR over the forecast time. Based on the technology used, it is believed that the Hepatitis E Diagnostic Tests Market is divided into ELISA, PCR, immunofluorescence, and many more.

In particular, the ELISA segment is predicted to expand at the fastest CAGR in the forecast. Based on the end user, the Hepatitis E diagnostic testing market is classified into diagnostic labs, hospitals, and research institutes. The hospital segment is predicted to expand at the fastest CAGR over the forecast time.

Hepatitis E Diagnostic Tests Market Report Scope and Segmentation

ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Hepatitis E symptoms, diagnosis, prevention and Treatment:

  • Symptoms: The symptoms of hepatitis E are: fatigue, fever, and loss of appetite. Other symptoms include stomach pain, dark urine, and jaundice. The virus could cause the death of the liver, especially for pregnant women and those suffering from other liver problems.
  • Diagnosis: An examination of blood identifies hepatitis E. The test can detect the presence of the virus in blood and reveal the hepatitis E virus. If you’ve been exposed to the virus, you might also require a liver biopsy to determine the damage.
  • Prevention: The most effective way to avoid the spread of hepatitis E is to follow strict hygiene. This means washing your hands often, mainly after you use the toilet or handling food items. Also, avoid contact with water or food items. Cleaning up your hands is essential if you come in contact with contaminated water or food items. If you’re planning to travel to a developing nation, getting vaccinated against Hepatitis E is necessary. This vaccine is secure and efficient and will help prevent this serious illness.
  • Treatment: There isn’t a specific treatment for hepatitis E. However; there are ways to control the symptoms and strengthen the liver. The first step to treating hepatitis E is to take a break and stay clear of alcohol. Alcohol can cause liver damage and cause the symptoms of hepatitis E more severe. Also, you should consume a balanced diet and stay clear of foods packed with sugar and fat. Many medications aid in relieving the signs of hepatitis E. They include painkillers, anti-nausea medication, and medication to ease diarrhea. Your physician will likely suggest you get ample sleep and avoid stressful situations. In certain instances, it is possible that hepatitis E could lead to liver failure. If this occurs, it is necessary to be admitted to the hospital and could require a liver transplant.

Hepatitis E Diagnostic Tests Market growth is expected to continue at a healthy pace in the coming years:

  • The rise in the prevalence of Hepatitis E is the primary driver of the expansion of the Hepatitis E Diagnostic Test Market. As per the World Health Organization (WHO), the majority of Hepatitis E is increasing and is now the main reason for acute viral hepatitis worldwide.
  • Additionally, there is a significant increase in the number of cases. WHO estimates that every year the number of cases of Hepatitis E and that 3 million patients require hospitalization for the condition.
  • The availability of reliable diagnostic tests is another reason driving the Hepatitis E Diagnostic Tests market’s growth. Numerous commercial diagnostic tests can be used to detect Hepatitis E, and more tests are being created. They have high sensitivity and specificity and can help confirm the diagnosis of hepatitis E.
  • The increasing awareness of the disease is another reason that is driving the growth of the Hepatitis E Diagnostic Tests Market. The increased awareness of the condition has led to earlier diagnosis and treatment, reducing its severity. Condition. Furthermore, the growing awareness is leading to increased demands for hepatitis E tests for diagnosis.

hepatitis e diagnostic tests market

Get more information on this report : Download Free Sample Pages

Hepatitis E Diagnostic Tests Market: Key Trends and Opportunities to 2030

The medical field is constantly developing and changing, and new diagnostic tests are created daily to stay up-to-date with the most recent advancements in medical technology. Hepatitis E can be described as a condition that affects the liver and is often challenging to identify. Many different diagnostic tests are available to detect Hepatitis E; however, the marketplace for such tests is constantly evolving. Here are some most significant developments affecting the hepatitis E diagnostic tests market:

1. New tests are continuously developed. As advances are developed in medical science, tests to detect Hepatitis E are being created. That means the demand for such tests is always changing as new test options are constantly available.

2. There’s a lot of competition on the Hepatitis E Diagnostic Market. A variety of businesses provide the diagnostic tests for Hepatitis E and are all fighting for the company. The prices for the tests can be very different, and shopping around for the best price is essential.

3. The Hepatitis E Diagnostic Tests Market is expanding. As increasing numbers of sufferers are diagnosed with Hepatitis E and hepatitis E, the need for tests to diagnose the disease is growing. This is a good thing for the companies offering these tests since the demand for these tests is increasing.

4. There are various types of tests that are available. Many different kinds of tests can detect hepatitis E. Each one has distinct advantages and disadvantages. It is essential to select the appropriate test for your requirements.

5. The Hepatitis E Diagnostic Testing Market is continuously evolving. As new advancements are developed in medical research, the market for diagnostic tests for hepatitis E is constantly evolving. It is essential to stay up-to-date with the most recent developments in this field to make the most informed choices about the tests you should use.

Hepatitis E diagnostic testing market faces several challenges:

The hepatitis E diagnostic test market is expected to expand shortly because more people are diagnosed with the disease. But, the market is facing many obstacles.

  • One of the major problems is the low precision of the current diagnostic tests. No test can definitively identify the presence of hepatitis E and the tests offered are often in error. This could lead to an incorrect diagnosis and the wrong treatment provided to patients.
  • Another issue is the expense of diagnostic tests. Hepatitis E tests can prove costly, making them out of the reach of many.
    Furthermore, there’s no cure for hepatitis E, and the infection is often fatal. There aren’t any particular treatments or vaccines for the disease, and it’s difficult to stop.
  • Another Challenge includes the lack of accuracy of current diagnostic tests, the high cost of diagnostic tests, and the lack of specific treatments or vaccines for the virus.

Hepatitis E Diagnostic Market Key Players:

There are several different companies that offer diagnostic tests for hepatitis E, and the Hepatitis E Diagnostic Testing Market is expected to grow in the coming years. Some of the key players in this market include Abbott Laboratories, Siemens Healthcare, and Roche Diagnostics.

  • Many significant manufacturers collaborate, partner, and acquire new market entrants with novel products. The combination of the technical expertise of major players with novel product techniques and materials from new players has resulted in new products that have improved functionality.

hepatitis e diagnostic tests market

Customize this report as per your requirement

Global Hepatitis E Test Market Segmentation:

There are two diagnostic tests to detect hepatitis E molecular and serological tests. Serology tests detect that antibodies to the virus are present within the blood and molecular tests determine whether the virus is present. The most commonly used serological test to see hepatitis E can be found in the enzyme-linked immunosorbent test (ELISA).

ELISA is a susceptible and precise test used to detect the presence of hepatitis E in acute and chronic stages. Other serological tests to detect Hepatitis E are the indirect fluorescence antibody test (IFAT) and the microparticle assay for agglutination (MAA). The molecular tests used to diagnose hepatitis E comprise polymerase chain reactions (PCR) and nucleic acid sequence-based amplification (NASBA) tests.

PCR is considered to be the more accurate and precise test to make the detection of hepatitis E. It is used to determine the virus’s presence at chronic and acute stages. NASBA is not as specific and sensitive test as PCR, however, it is more effective in being able to detect infection in stool specimens

Type
  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Other
End-user
  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care

Regions Covered in the Hepatitis E Diagnostic Testing Market:

Region

  • North America

United States

Canada

  • Europe

United Kingdom

Germany

France

Spain

Rest of Europe

  • Asia-Pacific

China

India

Japan

South Korea

Australia

Rest of Asia-Pacific

  • Latin America

Brazil

Mexico

Argentina

Rest of Latin America

  • Rest of world

Research Approach/Methodology

MWR’s research methodology is based on extensive use of secondary and primary data sources. The research involves the analysis of various aspects impacting the industry, including the policies of the government, the competitive landscape, the market environment and historical data, as well as current developments in the market technological innovation, emerging technologies, and the advancement of technology in related industries, and potential market risks as well as market barriers and issues.

Market Size Estimation of Hepatitis E Diagnostic Testing Market

Bottom-up and top-down approaches are employed to verify the size of the global product market and to estimate the size of the Hepatitis E Diagnostic Tests Market for companies’ regions, regions segment as well as product segments and applications (end users). The market estimates are built on the product’s retail price (excluding discounts offered by the distributor, manufacturer, wholesaler, trader, or).

Partially splits, market shares and breakdown of product segments are calculated based on the weights allocated to each segment based on their usage rate and average sale price. The regional splits of the total product market and sub-segments are determined by the per cent of adoption or use of the particular product within the specific region or country.

Top key players of the Hepatitis E Diagnostic Tests Market is determined through secondary data, and the market revenue is determined by secondary and primary approach. Secondary research comprised the study of financial and annual reports of the largest companies. In contrast, primary research involved extensive interviews with opinion makers and experts in the industry like experienced front-line employees, directors, CEOs, and marketing managers.

The market share, percentage splits and Growth Rate, as well as the market structure of the product, are calculated from secondary sources and then verified by primary sources. All potential factors that affect the markets are verified by conducting primary analysis, and then analyzed to obtain the final qualitative and quantitative results.

Market Breakdown, Data and Triangulation

After completing market engineering, including calculations of market statistics, size estimations, forecasting of market breakdown, and data triangulation, a lot of analysis are then conducted to collect details and to confirm the numbers to be verified.

Throughout the entire method of market engineering, top-down and bottom-up methods are were widely used, together with a variety of triangulation techniques for market estimation and forecasting of market trends for the entire market segment and sub-segments . A thorough analysis of quantitative data is also carried out using all the data gathered during the entire market engineering process to present important information throughout the research.

Data Sources

Secondary Sources

Secondary sources include annual reports, press releases, non-profit organizations and industry associations, government agencies, customs information, and others. This study focuses on extensive use of secondary sources, directories, databases, and directories like Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones and Company) and trading ECONOMICS and News Network, Statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS and company house documents CAS (American Chemical Society) and investor presentations along with SEC filings of corporations.

Secondary research are utilized to discover and gather details that could be used for a thorough technological, market-oriented and commercial analysis of the product market. It also helps collecting necessary information on the most prominent companies, market classification and segmentation by market trends from the lowest level, and critical technological and market developments.

Primary Sources

For the research process, different sources from both the demand and supply sides are being interviewed to collect quantitative and qualitative information. The primary sources on the supply side comprise companies (and their rivals) and opinion leaders, experts from the industry and research institutes, distributors, traders and dealers, raw material suppliers and producers, etc.

The primary sources for demand-side information are industry experts, such as business leaders, sales and marketing directors, directors of innovation and technology supply chain executives, the market (product buyers) and top executives from a variety of key organizations and companies operating globally.

The primary studies are then conducted to find segments, types of segmentation, price ranges, application of the product important company, raw materials supply and demand downstream as well as the status of the industry and its forecast, and the fundamental market dynamics, such as risk factors, influence factors and opportunities obstacles to market entry, trends in the industry, and the strategies of key players.

COVID-19 impact Analysis

To understand the impact of COVID, we must understand the supply chain of the industry and the value chain. By analyzing the supply chain, we understand the bottlenecks affecting the industry’s growth. And by analyzing the value chain, we understand what value each component adds to the entire industry. We then try to understand the COVID impact has on the industry by trying to find answers to the following questions:

  • How many jobs have been lost?
  • How many people have died due to COVID?
  • How did the Government respond, and what measures Government has taken to revive a Hepatitis E Diagnostic Tests Market industry?
  • How companies have responded to COVID?
  • What growth rate companies are expecting?

We also analyze their annual reports and press releases to understand their strategies post COVID. Then we move towards the primary research part and contact government officials and industry experts such as CEOs, COOs, Directors, VPs, Directors and Managers to understand what impact COVID has had on their businesses and what they are doing to cope with it.

We also try to understand their views regarding other financial aspects, such as recovery and obstacles in achieving pre-COVID growth and when they expect to achieve it.

Finally, after gathering the info from secondary and primary research, we try to form a model through which we gauge the COVID impact on a Hepatitis E Diagnostic Tests Market industry.

Market Forecast 

Each market is unique and has distinct features and risks that affect it in different ways. We try to discover patterns and commonalities in order to discover the real trends. Therefore, we use customized forecasting models that employ an amalgamation of traditional methods for forecasting time series modified to take into account the impact of current events that could affect the future and current prospects on the financial market.

The techniques we employ to forecast include a combination with regression analysis as well as exponential smoothing to align our analysis of predictive power with current trends and quickly shift business cycles. In the case of seasonal markets We employ hybrid forecasting techniques that incorporate spectral analysis in conjunction with the decomposition method of forecasting.

Frequently asked Questions about Hepatitis E Diagnostic Tests Market Study

What is the estimated size of the Hepatitis E Diagnostic Tests Market?

Global Hepatitis E Diagnostic Tests Market was estimated at USD 52.4 Million in 2021.

What is the forecasted growth rate of the Hepatitis E Diagnostic Tests Market?

Hepatitis E Diagnostic Tests Market is expected to grow at a CAGR of 4.5% between 2022 and 2030

Who are the key companies in the Global Hepatitis E Diagnostic Tests Market Report?

Key companies covered in the Hepatitis E Diagnostic Testing Market: Abbott Laboratories, Siemens Healthcare, Roche Diagnostics, Mikrogen GmBH, Siemens Ag, MP Biomedicals LLC,, Fast-track Diagnostics Ltd. and Others

What major regions are covered in the Hepatitis E Diagnostic Test Market Study

North America, Europe, Asia Pacific, Latin America, Middle East and Africa are the major regions covered in the Hepatitis E Diagnostic Tests Market Study

Which region is expected to dominate the Hepatitis E Diagnostic Tests Market?

Asia Pacific is expected to grow highest during the forecast period

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hepatitis E Diagnostic Tests Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Value Chain Analysis

    5.2. Disease Overview

    5.3. Regulatory approval process

6. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by Test Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by Test Type, 2018–2030

        6.2.1. HEV IgM ELISA Test kits

        6.2.2. HEV IgG ELISA Test kits

        6.2.3. RT-PCR Test kits

        6.2.4. Others

    6.3. Global Hepatitis E Diagnostic Tests Market Attractiveness, by Test Type

7. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by End User

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by End User, 2018–2030

        7.2.1. Hospitals

        7.2.2. Diagnostic Laboratories

        7.2.3. Research Centers

        7.2.4. Point of Care

    7.3. Global Hepatitis E Diagnostic Tests Market Attractiveness, by End User

8. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. North America Hepatitis E Diagnostic Tests Market Attractiveness, by Region

9. North America Hepatitis E Diagnostic Tests Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        9.2.1. HEV IgM ELISA Test kits

        9.2.2. HEV IgG ELISA Test kits

        9.2.3. RT-PCR Test kits

        9.2.4. Others

    9.3. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        9.3.1. Hospitals

        9.3.2. Diagnostic Laboratories

        9.3.3. Research Centers

        9.3.4. Point of Care

    9.4. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country, 2018–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        9.5.1. By Test Type

        9.5.2. By End User

        9.5.3. By Country

10. Europe Hepatitis E Diagnostic Tests Market Analysis and Forecast

    10.1. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        10.1.1. HEV IgM ELISA Test kits

        10.1.2. HEV IgG ELISA Test kits

        10.1.3. RT-PCR Test kits

        10.1.4. Others

    10.2. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        10.2.1. Hospitals

        10.2.2. Diagnostic Laboratories

        10.2.3. Research Centers

        10.2.4. Point of Care

    10.3. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        10.3.1. Germany

        10.3.2. U.K.

        10.3.3. France

        10.3.4. Spain

        10.3.5. Italy

        10.3.6. Rest of Europe

    10.4. Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        10.4.1. By Test Type

        10.4.2. By End User

        10.4.3. By Country/Sub-region

11. Asia Pacific Hepatitis E Diagnostic Tests Market Analysis and Forecast

    11.1. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        11.1.1. HEV IgM ELISA Test kits

        11.1.2. HEV IgG ELISA Test kits

        11.1.3. RT-PCR Test kits

        11.1.4. Others

    11.2. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        11.2.1. Hospitals

        11.2.2. Diagnostic Laboratories

        11.2.3. Research Centers

        11.2.4. Point of Care

    11.3. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        11.3.1. China

        11.3.2. Japan

        11.3.3. India

        11.3.4. Australia & New Zealand

        11.3.5. Rest of Asia Pacific

    11.4. Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        11.4.1. By Test Type

        11.4.2. By End User

        11.4.3. By Country/Sub-region

12. Latin America Hepatitis E Diagnostic Tests Market Analysis and Forecast

    12.1. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        12.1.1. HEV IgM ELISA Test kits

        12.1.2. HEV IgG ELISA Test kits

        12.1.3. RT-PCR Test kits

        12.1.4. Others

    12.2. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        12.2.1. Hospitals

        12.2.2. Diagnostic Laboratories

        12.2.3. Research Centers

        12.2.4. Point of Care

    12.3. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        12.3.1. Brazil

        12.3.2. Mexico

        12.3.3. Rest of Latin America Latin America

    12.4. Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        12.4.1. By Test Type

        12.4.2. By End User

        12.4.3. By Country/Sub-region

13. Middle East & Africa Hepatitis E Diagnostic Tests Market Analysis and Forecast

        13.1.1.

    13.2. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        13.2.1. HEV IgM ELISA Test kits

        13.2.2. HEV IgG ELISA Test kits

        13.2.3. RT-PCR Test kits

        13.2.4. Others

    13.3. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        13.3.1. Hospitals

        13.3.2. Diagnostic Laboratories

        13.3.3. Research Centers

        13.3.4. Point of Care

    13.4. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        13.5.1. By Test Type

        13.5.2. By End User

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis, by Company (2018)

    14.3. Competitive Business Strategies

    14.4. Company Profiles

        14.4.1. altona Diagnostics GmbH

            14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.1.2. Growth Strategies

            14.4.1.3. SWOT Analysis

        14.4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

            14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.2.2. Growth Strategies

            14.4.2.3. SWOT Analysis

        14.4.3. Biokit S.A.

            14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.3.2. Growth Strategies

            14.4.3.3. SWOT Analysis

        14.4.4. Dia.Pro – Diagnostic Bioprobes s.r.l

            14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.4.2. Growth Strategies

            14.4.4.3. SWOT Analysis

        14.4.5. F. Hoffmann-La Roche Ltd.

            14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.5.2. Growth Strategies

            14.4.5.3. SWOT Analysis

        14.4.6. Fast-track diagnostics Ltd.

            14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.6.2. Growth Strategies

            14.4.6.3. SWOT Analysis

        14.4.7. Fortress Diagnostics Limited

            14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.7.2. Growth Strategies

            14.4.7.3. SWOT Analysis

        14.4.8. Mikrogen GmBH

            14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.8.2. Growth Strategies

            14.4.8.3. SWOT Analysis

        14.4.9. MP Biomedicals, LLC.

            14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.9.2. Growth Strategies

            14.4.9.3. SWOT Analysis

        14.4.10. Primerdesign Ltd.

            14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.10.2. Growth Strategies

            14.4.10.3. SWOT Analysis

Segmentation

Type
  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Other
End-user
  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care

Major Companies

  • F. Hoffmann-La Roche Ltd.
  • Fortress Diagnostics Ltd.
  • Mikrogen GmBH
  • Abbott Laboratories
  • Siemens Ag
  • MP Biomedicals LLC
  • Fast-track Diagnostics Ltd.
  • Altana Diagnostics GmbH
  • Primerdesign Ltd.
  • Biokit S.A.
  • Fast-track diagnostics Ltd.
  • Others

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF